[Intravenous salicylamide therapy in rheumatic diseases].
作者信息
FRANKL R
出版信息
Munch Med Wochenschr. 1953 Apr 24;95(17):512-3.
PMID:13072425
Abstract
摘要
相似文献
1
[Intravenous salicylamide therapy in rheumatic diseases].[静脉注射水杨酰胺治疗风湿性疾病]
Munch Med Wochenschr. 1953 Apr 24;95(17):512-3.
2
[Contribution on an aminophenazone-salicylamide combined preparation in therapy of rheumatic conditions].[氨基非那宗 - 水杨酰胺联合制剂在风湿性疾病治疗中的作用]
Med Klin. 1956 Feb 3;51(5):181-2.
3
[Salicylamide as an analgesic and antirheumatic; results of a two year test].[水杨酰胺作为一种镇痛药和抗风湿药；两年试验结果]
Med Monatsschr. 1953 Mar;7(3):181-3.
4
Effectiveness of salicylamide as an analgesic and antirheumatic agent; evaluation of the double blindfold technique for studying analgesic drugs.水杨酰胺作为止痛和抗风湿药物的有效性；研究止痛药物的双盲技术评估。
J Am Med Assoc. 1955 Dec 24;159(17):1619-22. doi: 10.1001/jama.1955.02960340039009.
5
Treatment of rheumatic diseases.风湿性疾病的治疗。
Dtsch Med J. 1954 Oct 15;5(19-20):589-90.
6
7
[Parenteral and rectal administration of salicylamide; clinical study].水杨酰胺的胃肠外及直肠给药；临床研究
Gazz Med Ital. 1954 Sep;113(9):290-2.
8
[Effects of salicylic acid; cure of rheumatism by liver damage].[水杨酸的作用；通过肝损伤治愈风湿病]
Arztl Forsch. 1953 Mar 10;7(3):I/117-21.
9
[Further experience with salicylamide].[水杨酰胺的更多经验]
Sven Lakartidn. 1953 Aug 28;50(35):1796-1800.
10
SALICYLAMIDE.水杨酰胺
Lancet. 1951 Oct 6;2(6684):629.
引用本文的文献
1
Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework.在一个集成框架中，从化学、基因组和药理学数据预测药物-靶标相互作用。
Bioinformatics. 2010 Jun 15;26(12):i246-54. doi: 10.1093/bioinformatics/btq176.
Zotero 插件